Specifically, we have shown that primary melanomas display significant amounts of ETS-1, barely or not phosphorylated at T38, whereas metastatic cells show the reverse pattern, with low levels of ETS-1 highly phosphorylated at T38. This evidence concerns the gene ETS1 and melanoma.